Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC5039 Tat-gap19 Novel brain penetrant Cx43 hemichannel blocker
DCC5040 Tavarua Deoxyriboside A Potential neuroprotective agent, showing effects on cellular models of oxidative stress and neuroinflammation
DCC5041 Tazanolast Selective mast-cell-stabilizing agent, inhibiting ozone-induced airway hyperresponsiveness
DCC5042 Tb-2-081 Novel antagonist of IL-6 signaling
DCC5043 Tbbl-0000316 Novel antibiotic against Mycobacterium tuberculosis (Mtb), potently killing replicating, virulent Mtb H37Rv in a clavulanate-dependent manner
DCC5044 Tbdps-chc Novel potent MCT1 inhibitor, exhibiting good single agent anticancer efficacy properties
DCC5045 Tbe-31 Highly potent activator of Nrf2; Potent phase 2 cytoprotective pathway inducer and liver carcinogenesis blocker
DCC5046 Tbk1 Inhibitor-1 Novel TBK1/IKKε inhibitor
DCC5047 Tbz-07 Novel anti-angiogenesis and vascular disrupting agent, exhibiting moderate inhibitory cell proliferation activity
DCC5048 Tbz-19 Novel anti-angiogenesis and vascular disrupting agent, exhibiting moderate inhibitory cell proliferation activity
DCC5049 Tc299423 Novel agonist for nicotinic acetylcholine receptors (nAChRs), modestly selectively targeting α6β2 subtype
DCC5050 Tc-ac28 Novel potent and selective ligand of Brd2(2)
DCC5051 Tc-aqp1-1 Aquaporin 1 (AQP1) channel blocker
DCC5052 tc-c-14g Potent CB1 receptor inverse agonist
DCC5053 Tc-e 5006 Novel orally bioavailableγ-secretase modulator, reducing Aβ42 levels
DCC5054 FPR Agonist 43 Featured FPR Agonist 43 (compound 43) is a dual formyl peptide receptor 1 (FPR1) and formyl peptide receptor 2 (FPR2)/ALX agonist.
DCC5055 Tc-g1004 Potent and selective antagonist of adenosine A2A receptors
DCC5056 Tch-013 Non-competitive modulator of the proteasome inducing apoptosis a panel of myeloma and leukemia cell lines
DCC5057 Tc-i 2000 Featured Novel TRPM8 channel blocker
DCC5058 Tc-i 2014 Potent TRPM8 antagonist, exhibiting antiallodynic properties in pain models
DCC5059 tcmdc-125802 Antimalarial; Novel inhibitor of HepG2
DCC5060 Tcmdc-135051 Tfa Salt Novel Inhibitor of the malaria parasite protein kinase CLK3, inhibiting the development of liver-stage parasites, killing asexual blood-stage parasites at the trophozoite and schizont stages of the erythrocytic cycle, blocking the development of sexual ga
DCC5061 Tcn-237 Dihydrochloride Highly potent NR2B-selective NMDA receptor antagonist
DCC5062 Tc-ot-39 Nonpeptide partial agonist of oxytocin (OT) and vasopressin V2 receptors
DCC5063 Tc-s 7005 Potent and selective polo-like kinase 2 (PLK2) inhibitor
DCC5064 Tcs2312 Novel potent and selective CHK1 kinase inhibitor
DCC5065 Tcs2314 Featured Novel Integrin very late antigen-4 (VLA-4; α4β1) antagonist, blocking the activation of inflammatory cells.
DCC5066 Tcs-3035 Novel GPR35 agonist
DCC5067 Tcs-401 Insulin receptor sensitizing agent; Selective inhibitor of protein-tyrosine phosphatase 1B (PTP1B)
DCC5068 Tc-t 6000 Potent equilibrative nucleoside transporter 4 (ENT4) inhibitor

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X